NICE technology appraisal guidance
Issued: January 2012
TA245
Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults
This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta245
1 Guidance
1.1 Apixaban is recommended as an option for the prevention of venous thromboembolism in adults after elective hip or knee replacement surgery.